Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1989 Oct;84(4):1096–1104. doi: 10.1172/JCI114272

Binding of thrombin to subendothelial extracellular matrix. Protection and expression of functional properties.

R Bar-Shavit 1, A Eldor 1, I Vlodavsky 1
PMCID: PMC329765  PMID: 2794047

Abstract

We have analyzed the binding of thrombin, a serine protease with central roles in hemostasis, to the subendothelial extracellular matrix (ECM) produced by cultured endothelial cells. This substrate provides a thrombogenic surface where hemostasis is initiated. Binding was saturable and equilibrium was achieved after 3 h incubation with 125I-alpha-thrombin. Scatchard analysis of thrombin binding revealed the presence of 5.1 X 10(9) binding sites per squared millimeter ECM, with an apparent Kd of 13 nM. The catalytically blocked enzyme, diisofluorophosphate (DIP)-alpha-thrombin competed efficiently with 125I-alpha-thrombin, indicating that the binding was independent of its catalytic site. Moreover, high concentrations of the synthetic tetradecapeptide, representing residues 367-380 of thrombin B chain (the macrophage mitogenic domain of thrombin), competed with thrombin binding to ECM, indicating that the binding site may reside in the vicinity of "loop B" region. Thrombin binds to dermatan sulfate in the ECM, as demonstrated by the inhibition of 125I-alpha-thrombin binding to ECM pretreated with chondroitinase ABC, but not with heparitinase or chondroitinase AC. This stands in contrast to 125I-FGF (fibroblast growth factor) binding to ECM, which was inhibited by heparitinase but not by chondroitinase ABC, ECM-bound thrombin exhibits an exposed proteolytic site as monitored by the Chromozyme TH assay and by its ability to convert fibrinogen to a fibrin clot and to induce platelet activation as indicated by 14C-serotonin release. ECM-bound thrombin failed to form a complex with its major circulating inhibitor-antithrombin III (AT III), compared with rapid complex formation with soluble thrombin. We propose that thrombin binds to subendothelial ECM where it remains functionally active, localized, and protected from inactivation by circulating inhibitors.

Full text

PDF
1096

Images in this article

1101Image
on p.1101

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Awbrey B. J., Hoak J. C., Owen W. G. Binding of human thrombin to cultured human endothelial cells. J Biol Chem. 1979 May 25;254(10):4092–4095. [PubMed] [Google Scholar]
  2. BLOOM A. L. The release of thrombin from fibrin by fibrinolysin. Br J Haematol. 1962 Apr;8:129–133. doi: 10.1111/j.1365-2141.1962.tb06505.x. [DOI] [PubMed] [Google Scholar]
  3. Bar-Ner M., Eldor A., Wasserman L., Matzner Y., Cohen I. R., Fuks Z., Vlodavsky I. Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species. Blood. 1987 Aug;70(2):551–557. [PubMed] [Google Scholar]
  4. Bar-Shavit R., Kahn A. J., Mann K. G., Wilner G. D. Identification of a thrombin sequence with growth factor activity on macrophages. Proc Natl Acad Sci U S A. 1986 Feb;83(4):976–980. doi: 10.1073/pnas.83.4.976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bar-Shavit R., Kahn A., Fenton J. W., 2nd, Wilner G. D. Chemotactic response of monocytes to thrombin. J Cell Biol. 1983 Jan;96(1):282–285. doi: 10.1083/jcb.96.1.282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bar-Shavit R., Kahn A., Fenton J. W., 2nd, Wilner G. D. Receptor-mediated chemotactic response of a macrophage cell line (J774) to thrombin. Lab Invest. 1983 Dec;49(6):702–707. [PubMed] [Google Scholar]
  7. Bar-Shavit R., Kahn A., Wilner G. D., Fenton J. W., 2nd Monocyte chemotaxis: stimulation by specific exosite region in thrombin. Science. 1983 May 13;220(4598):728–731. doi: 10.1126/science.6836310. [DOI] [PubMed] [Google Scholar]
  8. Bar-Shavit R., Wilner G. D. Mediation of cellular events by thrombin. Int Rev Exp Pathol. 1986;29:213–241. [PubMed] [Google Scholar]
  9. Bashkin P., Doctrow S., Klagsbrun M., Svahn C. M., Folkman J., Vlodavsky I. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry. 1989 Feb 21;28(4):1737–1743. doi: 10.1021/bi00430a047. [DOI] [PubMed] [Google Scholar]
  10. Bing D. H., Feldmann R. J., Fenton J. W., 2nd Structure-function relationships of thrombin based on the computer-generated three-dimensional model of the B chain of bovine thrombin. Ann N Y Acad Sci. 1986;485:104–119. doi: 10.1111/j.1749-6632.1986.tb34572.x. [DOI] [PubMed] [Google Scholar]
  11. Camussi G., Aglietta M., Malavasi F., Tetta C., Piacibello W., Sanavio F., Bussolino F. The release of platelet-activating factor from human endothelial cells in culture. J Immunol. 1983 Nov;131(5):2397–2403. [PubMed] [Google Scholar]
  12. Carney D. H., Cunningham D. D. Role of specific cell surface receptors in thrombin-stimulated cell division. Cell. 1978 Dec;15(4):1341–1349. doi: 10.1016/0092-8674(78)90059-4. [DOI] [PubMed] [Google Scholar]
  13. Chen L. B., Buchanan J. M. Mitogenic activity of blood components. I. Thrombin and prothrombin. Proc Natl Acad Sci U S A. 1975 Jan;72(1):131–135. doi: 10.1073/pnas.72.1.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Fenton J. W., 2nd, Fasco M. J., Stackrow A. B. Human thrombins. Production, evaluation, and properties of alpha-thrombin. J Biol Chem. 1977 Jun 10;252(11):3587–3598. [PubMed] [Google Scholar]
  15. Folkman J., Klagsbrun M., Sasse J., Wadzinski M., Ingber D., Vlodavsky I. A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane. Am J Pathol. 1988 Feb;130(2):393–400. [PMC free article] [PubMed] [Google Scholar]
  16. Fridman R., Alon Y., Doljanski F., Fuks Z., Vlodavsky I. Cell interaction with the extracellular matrices produced by endothelial cells and fibroblasts. Exp Cell Res. 1985 Jun;158(2):461–476. doi: 10.1016/0014-4827(85)90469-0. [DOI] [PubMed] [Google Scholar]
  17. Galdal K. S., Evensen S. A., Nilsen E. The effect of thrombin on fibronectin in cultured human endothelial cells. Thromb Res. 1985 Mar 1;37(5):583–593. doi: 10.1016/0049-3848(85)90091-x. [DOI] [PubMed] [Google Scholar]
  18. Garcia J. G., Siflinger-Birnboim A., Bizios R., Del Vecchio P. J., Fenton J. W., 2nd, Malik A. B. Thrombin-induced increase in albumin permeability across the endothelium. J Cell Physiol. 1986 Jul;128(1):96–104. doi: 10.1002/jcp.1041280115. [DOI] [PubMed] [Google Scholar]
  19. Gelehrter T. D., Sznycer-Laszuk R. Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells. J Clin Invest. 1986 Jan;77(1):165–169. doi: 10.1172/JCI112271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Glenn K. C., Carney D. H., Fenton J. W., 2nd, Cunningham D. D. Thrombin active site regions required for fibroblast receptor binding and initiation of cell division. J Biol Chem. 1980 Jul 25;255(14):6609–6616. [PubMed] [Google Scholar]
  21. Gospodarowicz D., Delgado D., Vlodavsky I. Permissive effect of the extracellular matrix on cell proliferation in vitro. Proc Natl Acad Sci U S A. 1980 Jul;77(7):4094–4098. doi: 10.1073/pnas.77.7.4094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Gospodarowicz D., Mescher A. L., Birdwell C. R. Stimulation of corneal endothelial cell proliferations in vitro by fibroblast and epidermal growth factors. Exp Eye Res. 1977 Jul;25(1):75–89. doi: 10.1016/0014-4835(77)90248-2. [DOI] [PubMed] [Google Scholar]
  23. Hanson S. R., Harker L. A. Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone. Proc Natl Acad Sci U S A. 1988 May;85(9):3184–3188. doi: 10.1073/pnas.85.9.3184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Harlan J. M., Thompson P. J., Ross R. R., Bowen-Pope D. F. Alpha-thrombin induces release of platelet-derived growth factor-like molecule(s) by cultured human endothelial cells. J Cell Biol. 1986 Sep;103(3):1129–1133. doi: 10.1083/jcb.103.3.1129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Hatton M. W., Dejana E., Cazenave J. P., Regoeczi E., Mustard J. F. Heparin inhibits thrombin binding to rabbit thoracic aorta endothelium. J Lab Clin Med. 1980 Nov;96(5):861–870. [PubMed] [Google Scholar]
  26. Hatton M. W., Moar S. L. A role for pericellular proteoglycan in the binding of thrombin or antithrombin III by the blood vessel endothelium? The effects of proteoglycan-degrading enzymes and glycosaminoglycan-binding proteins on 125I-thrombin binding by the rabbit thoracic aorta in vitro. Thromb Haemost. 1985 Apr 22;53(2):228–234. [PubMed] [Google Scholar]
  27. Jaffe E. A., Hoyer L. W., Nachman R. L. Synthesis of von Willebrand factor by cultured human endothelial cells. Proc Natl Acad Sci U S A. 1974 May;71(5):1906–1909. doi: 10.1073/pnas.71.5.1906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Jesty J. The kinetics of inhibition of alpha-thrombin in human plasma. J Biol Chem. 1986 Aug 5;261(22):10313–10318. [PubMed] [Google Scholar]
  29. Knudsen B. S., Silverstein R. L., Leung L. L., Harpel P. C., Nachman R. L. Binding of plasminogen to extracellular matrix. J Biol Chem. 1986 Aug 15;261(23):10765–10771. [PubMed] [Google Scholar]
  30. Laposata M., Dovnarsky D. K., Shin H. S. Thrombin-induced gap formation in confluent endothelial cell monolayers in vitro. Blood. 1983 Sep;62(3):549–556. [PubMed] [Google Scholar]
  31. Liotta L. A., Goldfarb R. H., Brundage R., Siegal G. P., Terranova V., Garbisa S. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res. 1981 Nov;41(11 Pt 1):4629–4636. [PubMed] [Google Scholar]
  32. Liotta L. A. Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res. 1986 Jan;46(1):1–7. [PubMed] [Google Scholar]
  33. Loskutoff D. J., Edgington T. E. Synthesis of a fibrinolytic activator and inhibitor by endothelial cells. Proc Natl Acad Sci U S A. 1977 Sep;74(9):3903–3907. doi: 10.1073/pnas.74.9.3903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Loskutoff D. J. Effect of thrombin on the fibrinolytic activity of cultured bovine endothelial cells. J Clin Invest. 1979 Jul;64(1):329–332. doi: 10.1172/JCI109457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Madri J. A., Roll F. J., Furthmayr H., Foidart J. M. Ultrastructural localization of fibronectin and laminin in the basement membranes of the murine kidney. J Cell Biol. 1980 Aug;86(2):682–687. doi: 10.1083/jcb.86.2.682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Matzner Y., Bar-Ner M., Yahalom J., Ishai-Michaeli R., Fuks Z., Vlodavsky I. Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes. J Clin Invest. 1985 Oct;76(4):1306–1313. doi: 10.1172/JCI112104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Nakajima M., Irimura T., Di Ferrante D., Di Ferrante N., Nicolson G. L. Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines. Science. 1983 May 6;220(4597):611–613. doi: 10.1126/science.6220468. [DOI] [PubMed] [Google Scholar]
  38. Naparstek Y., Cohen I. R., Fuks Z., Vlodavsky I. Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase. Nature. 1984 Jul 19;310(5974):241–244. doi: 10.1038/310241a0. [DOI] [PubMed] [Google Scholar]
  39. Olivecrona T., Egelrud T., Iverius P. H., Lindahl U. Evidence for an ionic binding of lipoprotein lipase to heparin. Biochem Biophys Res Commun. 1971 May 7;43(3):524–529. doi: 10.1016/0006-291x(71)90645-0. [DOI] [PubMed] [Google Scholar]
  40. Pearson J. D., Gordon J. L. Vascular endothelial and smooth muscle cells in culture selectively release adenine nucleotides. Nature. 1979 Oct 4;281(5730):384–386. doi: 10.1038/281384a0. [DOI] [PubMed] [Google Scholar]
  41. Preissner K. T., Müller-Berghaus G. S protein modulates the heparin-catalyzed inhibition of thrombin by antithrombin III. Evidence for a direct interaction of S protein with heparin. Eur J Biochem. 1986 May 2;156(3):645–650. doi: 10.1111/j.1432-1033.1986.tb09626.x. [DOI] [PubMed] [Google Scholar]
  42. Prescott S. M., Zimmerman G. A., McIntyre T. M. Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin. Proc Natl Acad Sci U S A. 1984 Jun;81(11):3534–3538. doi: 10.1073/pnas.81.11.3534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Rosenberg R. D., Damus P. S. The purification and mechanism of action of human antithrombin-heparin cofactor. J Biol Chem. 1973 Sep 25;248(18):6490–6505. [PubMed] [Google Scholar]
  44. Savion N., Isaacs J. D., Gospodarowicz D., Shuman M. A. Internalization and degradation of thrombin and up regulation of thrombin-binding sites in corneal endothelial cells. J Biol Chem. 1981 May 10;256(9):4514–4519. [PubMed] [Google Scholar]
  45. Savion N., Vlodavsky I., Fuks Z. Interaction of T lymphocytes and macrophages with cultured vascular endothelial cells: attachment, invasion, and subsequent degradation of the subendothelial extracellular matrix. J Cell Physiol. 1984 Feb;118(2):169–178. doi: 10.1002/jcp.1041180209. [DOI] [PubMed] [Google Scholar]
  46. Smith J. C., Singh J. P., Lillquist J. S., Goon D. S., Stiles C. D. Growth factors adherent to cell substrate are mitogenically active in situ. Nature. 1982 Mar 11;296(5853):154–156. doi: 10.1038/296154a0. [DOI] [PubMed] [Google Scholar]
  47. Sporn L. A., Marder V. J., Wagner D. D. von Willebrand factor released from Weibel-Palade bodies binds more avidly to extracellular matrix than that secreted constitutively. Blood. 1987 May;69(5):1531–1534. [PubMed] [Google Scholar]
  48. Stern D., Nawroth P., Handley D., Kisiel W. An endothelial cell-dependent pathway of coagulation. Proc Natl Acad Sci U S A. 1985 Apr;82(8):2523–2527. doi: 10.1073/pnas.82.8.2523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Tam S. W., Fenton J. W., 2nd, Detwiler T. C. Platelet thrombin receptors. Binding of alpha-thrombin is coupled to signal generation by a chymotrypsin-sensitive mechanism. J Biol Chem. 1980 Jul 25;255(14):6626–6632. [PubMed] [Google Scholar]
  50. Taylor S., Folkman J. Protamine is an inhibitor of angiogenesis. Nature. 1982 May 27;297(5864):307–312. doi: 10.1038/297307a0. [DOI] [PubMed] [Google Scholar]
  51. Vlodavsky I., Fuks Z., Bar-Ner M., Ariav Y., Schirrmacher V. Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis. Cancer Res. 1983 Jun;43(6):2704–2711. [PubMed] [Google Scholar]
  52. Vlodavsky I., Lui G. M., Gospodarowicz D. Morphological appearance, growth behavior and migratory activity of human tumor cells maintained on extracellular matrix versus plastic. Cell. 1980 Mar;19(3):607–616. doi: 10.1016/s0092-8674(80)80037-7. [DOI] [PubMed] [Google Scholar]
  53. Wang C. L., Miyata T., Weksler B., Rubin A. L., Stenzel K. H. Collagen-induced platelet aggregation and release. II Critical size and structural requirements of collagen. Biochim Biophys Acta. 1978 Dec 18;544(3):568–577. doi: 10.1016/0304-4165(78)90331-8. [DOI] [PubMed] [Google Scholar]
  54. Weksler B. B., Ley C. W., Jaffe E. A. Stimulation of endothelial cell prostacyclin production by thrombin, trypsin, and the ionophore A 23187. J Clin Invest. 1978 Nov;62(5):923–930. doi: 10.1172/JCI109220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Wilner G. D., Danitz M. P., Mudd M. S., Hsieh K. H., Fenton J. W., 2nd Selective immobilization of alpha-thrombin by surface-bound fibrin. J Lab Clin Med. 1981 Mar;97(3):403–411. [PubMed] [Google Scholar]
  56. Wilner G. D., Thomas D. W., Nossel H. L., Robbins P. F., Mudd M. S. Immunochemical analysis of rabbit antihuman fibrinopeptide B antibodies. Biochemistry. 1979 Nov 13;18(23):5078–5082. doi: 10.1021/bi00590a009. [DOI] [PubMed] [Google Scholar]
  57. Yahalom J., Eldor A., Fuks Z., Vlodavsky I. Degradation of sulfated proteoglycans in the subendothelial extracellular matrix by human platelet heparitinase. J Clin Invest. 1984 Nov;74(5):1842–1849. doi: 10.1172/JCI111603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. de Groot P. G., Reinders J. H., Sixma J. J. Perturbation of human endothelial cells by thrombin or PMA changes the reactivity of their extracellular matrix towards platelets. J Cell Biol. 1987 Mar;104(3):697–704. doi: 10.1083/jcb.104.3.697. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES